Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000170856 | SCV000223411 | benign | not specified | 2014-10-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000474395 | SCV000562850 | benign | Brugada syndrome 4 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617740 | SCV000735162 | likely benign | Cardiovascular phenotype | 2015-11-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000474395 | SCV002799169 | likely benign | Brugada syndrome 4 | 2022-02-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000170856 | SCV005077326 | benign | not specified | 2024-04-08 | criteria provided, single submitter | clinical testing |